Skip to main content
Top
Published in: Archives of Orthopaedic and Trauma Surgery 6/2007

01-08-2007 | Trauma Surgery

The non-steroidal anti-inflammatory drug diclofenac reduces appearance of osteoblasts in bone defect healing in rats

Authors: G. D. Krischak, P. Augat, R. Blakytny, L. Claes, L. Kinzl, A. Beck

Published in: Archives of Orthopaedic and Trauma Surgery | Issue 6/2007

Login to get access

Abstract

Introduction

Non-steroidal anti-inflammatory drug (NSAID) is well known to significantly delay fracture healing. Results from in vitro studies implicate an impairment of osteoblast proliferation due to NSAIDs during the initial stages of healing. We studied whether diclofenac, a non-selective NSAID, also impairs appearance of osteoblasts in vivo during the early phase of healing (at 10 days).

Materials and methods

Two defects (Ø 1.1 mm) were drilled within distal femurs of 20 male Wistar rats. Ten rats received diclofenac continuously; the other obtained a placebo until sacrificing at 10 days. Osteoblast proliferation was assessed by cell counting using light microscopy, and bone mineral density (BMD) was measured using pQCT.

Results

Osteoblast counts from the centre of bone defect were significantly reduced in the diclofenac group (median 73.5 ± 8.4 cells/grid) compared to animals fed with placebo (median 171.5 ± 13.9 cells/grid). BMD within the defect showed a significant reduction after diclofenac administration (median 111.5 ± 9.3 mg/cm³) compared to the placebo group (median 177 ± 45.4 mg/cm³).

Conclusion

The reduced appearance of osteoblasts in vivo implicates an inhibiting effect of diclofenac on osteoblasts at a very early level of bone healing. The inhibition of proliferation and migration of osteoblasts, or differentiation from progenitor cells, is implicated in the delay of fracture healing after NSAID application.
Literature
1.
go back to reference al Balla SR, el Sayed YM, al Meshal MA, Gouda MW (1994) The effects of cholestyramine and colestipol on the absorption of diclofenac in man. Int J Clin Pharmacol Ther 32:441–445PubMed al Balla SR, el Sayed YM, al Meshal MA, Gouda MW (1994) The effects of cholestyramine and colestipol on the absorption of diclofenac in man. Int J Clin Pharmacol Ther 32:441–445PubMed
2.
go back to reference Arikawa T, Omura K, Morita I (2004) Regulation of bone morphogenetic protein-2 expression by endogenous prostaglandin E2 in human mesenchymal stem cells. J Cell Physiol 200:400–406PubMedCrossRef Arikawa T, Omura K, Morita I (2004) Regulation of bone morphogenetic protein-2 expression by endogenous prostaglandin E2 in human mesenchymal stem cells. J Cell Physiol 200:400–406PubMedCrossRef
3.
go back to reference Beck A, Krischak G, Sorg T, Augat P, Farker K, Merkel U, Kinzl L, Claes L (2003) Influence of diclofenac (group of nonsteroidal anti-inflammatory drugs) on fracture healing. Arch Orthop Trauma Surg 123:327–332PubMedCrossRef Beck A, Krischak G, Sorg T, Augat P, Farker K, Merkel U, Kinzl L, Claes L (2003) Influence of diclofenac (group of nonsteroidal anti-inflammatory drugs) on fracture healing. Arch Orthop Trauma Surg 123:327–332PubMedCrossRef
4.
go back to reference Bhandari M, Schemitsch EH (2002) Bone formation following intramedullary femoral reaming is decreased by indomethacin and antibodies to insulin-like growth factors. J Orthop Trauma 16:717–722PubMedCrossRef Bhandari M, Schemitsch EH (2002) Bone formation following intramedullary femoral reaming is decreased by indomethacin and antibodies to insulin-like growth factors. J Orthop Trauma 16:717–722PubMedCrossRef
5.
go back to reference Blair HC, Athanasou NA (2004) Recent advances in osteoclast biology and pathological bone resorption. Histol Histopathol 19:189–199PubMed Blair HC, Athanasou NA (2004) Recent advances in osteoclast biology and pathological bone resorption. Histol Histopathol 19:189–199PubMed
6.
go back to reference Bort R, Ponsoda X, Jover R, Gomez-Lechon MJ, Castell JV (1999) Diclofenac toxicity to hepatocytes: a role for drug metabolism in cell toxicity. J Pharmacol Exp Ther 288:65–72PubMed Bort R, Ponsoda X, Jover R, Gomez-Lechon MJ, Castell JV (1999) Diclofenac toxicity to hepatocytes: a role for drug metabolism in cell toxicity. J Pharmacol Exp Ther 288:65–72PubMed
7.
go back to reference Boushel R, Langberg H, Risum N, Kjaer M (2004) Regulation of blood flow by prostaglandins. Curr Vasc Pharmacol 2:191–197PubMedCrossRef Boushel R, Langberg H, Risum N, Kjaer M (2004) Regulation of blood flow by prostaglandins. Curr Vasc Pharmacol 2:191–197PubMedCrossRef
8.
go back to reference Brown KM, Saunders MM, Kirsch T, Donahue HJ, Reid JS (2004) Effect of COX-2-specific inhibition on fracture-healing in the rat femur. J Bone Joint Surg Am 86-A:116–123PubMed Brown KM, Saunders MM, Kirsch T, Donahue HJ, Reid JS (2004) Effect of COX-2-specific inhibition on fracture-healing in the rat femur. J Bone Joint Surg Am 86-A:116–123PubMed
9.
go back to reference Dekel S, Lenthall G, Francis MJO (1981) Release of prostaglandins from bone and muscle after tibial fracture. An experimental study in rabbits. J Bone Joint Surg Br 63-B:185–189PubMed Dekel S, Lenthall G, Francis MJO (1981) Release of prostaglandins from bone and muscle after tibial fracture. An experimental study in rabbits. J Bone Joint Surg Br 63-B:185–189PubMed
10.
go back to reference Dinarello CA (2002) The IL-1 family and inflammatory diseases. Clin Exp Rheumatol 20:S1–S13PubMed Dinarello CA (2002) The IL-1 family and inflammatory diseases. Clin Exp Rheumatol 20:S1–S13PubMed
11.
go back to reference Endo K, Sairyo K, Komatsubara S, Sasa T, Egawa H, Yonekura D, Adachi K, Ogawa T, Murakami R, Yasui N (2002) Cyclooxygenase-2 inhibitor inhibits the fracture healing. J Physiol Anthropol Appl Human Sci 21:235–238PubMedCrossRef Endo K, Sairyo K, Komatsubara S, Sasa T, Egawa H, Yonekura D, Adachi K, Ogawa T, Murakami R, Yasui N (2002) Cyclooxygenase-2 inhibitor inhibits the fracture healing. J Physiol Anthropol Appl Human Sci 21:235–238PubMedCrossRef
12.
go back to reference Harizi H, Norbert G (2004) Inhibition of IL-6, TNF-alpha, and cyclooxygenase-2 protein expression by prostaglandin E2-induced Il-10 in bone marrow-derived dendritic cells. Cell Immunol 228:99–109PubMedCrossRef Harizi H, Norbert G (2004) Inhibition of IL-6, TNF-alpha, and cyclooxygenase-2 protein expression by prostaglandin E2-induced Il-10 in bone marrow-derived dendritic cells. Cell Immunol 228:99–109PubMedCrossRef
13.
go back to reference Ho ML, Chang JK, Chuang LY, Hsu HK, Wang GJ (1999) Effects of nonsteroidal anti-inflammatory drugs and prostaglandins on osteoblastic functions. Biochem Pharmacol 58:983–990PubMedCrossRef Ho ML, Chang JK, Chuang LY, Hsu HK, Wang GJ (1999) Effects of nonsteroidal anti-inflammatory drugs and prostaglandins on osteoblastic functions. Biochem Pharmacol 58:983–990PubMedCrossRef
14.
go back to reference Høgevold HE, Grøgaard B, Reikerås O (1992) Effects of short-term treatment with corticosteroids and indomethacin on bone healing. A mechanical study of osteotomies in rats. Acta Orthop Scand 63:607–611PubMed Høgevold HE, Grøgaard B, Reikerås O (1992) Effects of short-term treatment with corticosteroids and indomethacin on bone healing. A mechanical study of osteotomies in rats. Acta Orthop Scand 63:607–611PubMed
15.
go back to reference Kaspar D, Hedrich CM, Schmidt C, Liedert A, Claes LE, Ignatius AA (2005) Diclofenac hemmt die Proliferation und Matrixbildung osteoblastärer Zellen. Unfallchirurg 108:18–24PubMedCrossRef Kaspar D, Hedrich CM, Schmidt C, Liedert A, Claes LE, Ignatius AA (2005) Diclofenac hemmt die Proliferation und Matrixbildung osteoblastärer Zellen. Unfallchirurg 108:18–24PubMedCrossRef
16.
go back to reference Krischak GD, Augat P, Sorg T, Blakytny R, KInzl L, Claes L, Beck A (2007) Effects of diclofenac on periosteal callus maturation in osteotomy healing in an animal model. Arch Orthop Trauma Surg 127:3–9PubMedCrossRef Krischak GD, Augat P, Sorg T, Blakytny R, KInzl L, Claes L, Beck A (2007) Effects of diclofenac on periosteal callus maturation in osteotomy healing in an animal model. Arch Orthop Trauma Surg 127:3–9PubMedCrossRef
17.
go back to reference Li TF, Zuscik MJ, Ionescu AM, Zhang X, Rosier RN, Schwarz EM, Drissi H, O’Keefe RJ (2004) PGE2 inhibits chondrocyte differentiation through PKA and PKC signaling. Exp Cell Res 300:159–169PubMedCrossRef Li TF, Zuscik MJ, Ionescu AM, Zhang X, Rosier RN, Schwarz EM, Drissi H, O’Keefe RJ (2004) PGE2 inhibits chondrocyte differentiation through PKA and PKC signaling. Exp Cell Res 300:159–169PubMedCrossRef
18.
go back to reference Liles JH, Flecknell PA (1994) A comparison of the effects of buprenorphine, carprofen and flunixin following laparotomy in rats. J Vet Pharmacol Ther 17:284–290PubMed Liles JH, Flecknell PA (1994) A comparison of the effects of buprenorphine, carprofen and flunixin following laparotomy in rats. J Vet Pharmacol Ther 17:284–290PubMed
19.
go back to reference Matziolis G, Rau HM, Klever P, Erli HJ, Paar O (2002) Beeinflussung humaner Osteoblasten durch verschiedene Analgetika. Unfallchirurg 105:527–531PubMedCrossRef Matziolis G, Rau HM, Klever P, Erli HJ, Paar O (2002) Beeinflussung humaner Osteoblasten durch verschiedene Analgetika. Unfallchirurg 105:527–531PubMedCrossRef
20.
go back to reference Needleman P, Turk J, Jakschik BA, Morrison AR, Lefkowith JB (1986) Arachidonic acid metabolism. Annu Rev Biochem 55:69–102PubMedCrossRef Needleman P, Turk J, Jakschik BA, Morrison AR, Lefkowith JB (1986) Arachidonic acid metabolism. Annu Rev Biochem 55:69–102PubMedCrossRef
21.
go back to reference Okamoto F, Kajiya H, Fukushima H, Jimi E, Okabe K (2004) Prostaglandin E2 activates outwardly rectifying Cl(-) channels via a cAMP-dependent pathway and reduces cell motility in rat osteoclasts. Am J Physiol Cell Physiol 287:114–124CrossRef Okamoto F, Kajiya H, Fukushima H, Jimi E, Okabe K (2004) Prostaglandin E2 activates outwardly rectifying Cl(-) channels via a cAMP-dependent pathway and reduces cell motility in rat osteoclasts. Am J Physiol Cell Physiol 287:114–124CrossRef
22.
go back to reference Raisz LG, Woodiel FN (2003) Effects of selective prostaglandin EP2 and EP4 receptor agonists on bone resorption and formation on fetal rat organ cultures. Prostaglandins Other Lipid Mediat 71:287–292PubMedCrossRef Raisz LG, Woodiel FN (2003) Effects of selective prostaglandin EP2 and EP4 receptor agonists on bone resorption and formation on fetal rat organ cultures. Prostaglandins Other Lipid Mediat 71:287–292PubMedCrossRef
23.
go back to reference Shamir D, Keila S, Weinreb M (2004) A selective EP4 receptor antagonist abrogates the stimulation of osteoblast recruitment from bone marrow stromal cells by prostaglandin E2 in vivo and in vitro. Bone 34:157–162PubMedCrossRef Shamir D, Keila S, Weinreb M (2004) A selective EP4 receptor antagonist abrogates the stimulation of osteoblast recruitment from bone marrow stromal cells by prostaglandin E2 in vivo and in vitro. Bone 34:157–162PubMedCrossRef
24.
go back to reference Vane JR, Botting RM (1998) Mechanism of action of antiinflammatory drugs. Int J Tissue React 20:3–15PubMed Vane JR, Botting RM (1998) Mechanism of action of antiinflammatory drugs. Int J Tissue React 20:3–15PubMed
25.
go back to reference Vassiliou E, Jing H, Ganea D (2003) Prostaglandin E2 inhibits TNF production in murine bone marrow-derived dendritic cells. Cell Immunol 223:120–132PubMedCrossRef Vassiliou E, Jing H, Ganea D (2003) Prostaglandin E2 inhibits TNF production in murine bone marrow-derived dendritic cells. Cell Immunol 223:120–132PubMedCrossRef
26.
go back to reference Vrotsos Y, Miller SC, Marks SC Jr (2003) Prostaglandin E–a powerful anabolic agent for generalized or site-specific bone formation. Crit Rev Eukaryot Gene Expr 13:255–263PubMedCrossRef Vrotsos Y, Miller SC, Marks SC Jr (2003) Prostaglandin E–a powerful anabolic agent for generalized or site-specific bone formation. Crit Rev Eukaryot Gene Expr 13:255–263PubMedCrossRef
Metadata
Title
The non-steroidal anti-inflammatory drug diclofenac reduces appearance of osteoblasts in bone defect healing in rats
Authors
G. D. Krischak
P. Augat
R. Blakytny
L. Claes
L. Kinzl
A. Beck
Publication date
01-08-2007
Publisher
Springer-Verlag
Published in
Archives of Orthopaedic and Trauma Surgery / Issue 6/2007
Print ISSN: 0936-8051
Electronic ISSN: 1434-3916
DOI
https://doi.org/10.1007/s00402-007-0288-9

Other articles of this Issue 6/2007

Archives of Orthopaedic and Trauma Surgery 6/2007 Go to the issue